Kisho

Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy

NIH Grants & Funding for Alzheimer Disease 13 | Kisho | Kisho

Back to Alzheimer Disease 13

Alzheimer Disease 13 — NIH Grants & Funding

Active and recent NIH-funded research on Alzheimer Disease 13. Data from NIH RePORTER, last 36 months.

MONDO:0012630

NIH-funded research on Alzheimer Disease 13

active grants

institutions

researchers

new in last 12 mo.

$109.8M in NIH funding over the last 36 months. Data from NIH RePORTER.

I'm looking for:

Or filter by research focus

Only show active grants

Basic Science(21)

Basic ScienceRF1Active

Hyperactivity of the thalamo-hippocampal-prefrontal circuit as a mechanism for anxiety in Alzheimer disease - Resubmission - 1

Masurkar, Arjun·NEW YORK UNIVERSITY SCHOOL OF MEDICINE·NEW YORK, NY

$2,044,038 (FY2024)

Alzheimer Disease 13 — NIH Grants & Funding

Basic Science(21)

Hyperactivity of the thalamo-hippocampal-prefrontal circuit as a mechanism for anxiety in Alzheimer disease - Resubmission - 1

Develop and Validate a Mouse Model for Alzheimer Disease in Down Syndrome

LRP1-tau interactions and Alzheimer Disease

Extracellular vesicle transport of brain-derived proteins to the blood in Alzheimer disease

Differential impact of Alzheimer disease on neuronal subpopulations in dorsal hippocampal CA1

Role of MyD88 signaling in systemic inflammation and Alzheimer disease

TREM2-endogenous ligand interactions in Alzheimer disease

Mechanism of CD33 receptor signaling in Alzheimer disease

Circadian changes in network excitability and Alzheimer disease pathogenesis

Elucidating the Role of Endothelial Dysfunction in Alzheimer Disease: Towards A New Data-Driven Disease Model

Translational(5)

Alzheimer Disease Genetic Analysis to Identify Potential Therapeutic Targets (ADAPTT)

Development of a therapeutic nanobody targeting brain TNFa for the treatment of Alzheimer Disease

Drugs repositioning to target TREM2 in Alzheimer disease

Brain extracellular matrix changes during normal aging and in Alzheimer disease

Novel Combinations of Natural Product Compounds for Treatment of Alzheimer Disease and Related Dementias

Clinical(6)

Alzheimer Disease Research Center

CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease

Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease

Escitalopram for Agitation in Alzheimer Disease

Deep-Learning-Augmented Quantitative Gradient Recalled Echo (DLA-qGRE) MRI for in vivo Clinical Evaluation of Brain Microstructural Neurodegeneration in Alzheimer Disease

Neuropathological changes underlying clinical heterogeneity in Alzheimer disease

Epi / Nat. History(2)

ALZHEIMERS RESEARCH PROJECT: Early Markers of Alzheimer Disease

Optimization of Glutathione Levels and Alzheimer Disease Risk in African Americans

Gene/Cell Therapy(1)

The Alzheimer Disease Sequence Analysis Collaborative

Biomarker / Dx(5)

Antecedent Biomarkers for Alzheimer Disease: The Adult Children Study

In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI

Discovery of therapeutic nanobodies targeting brain TNF-α for the treatment of Alzheimer Disease

Soluble TREM2 regulation of microglial function in Alzheimer disease

A novel therapeutic approach for Alzheimer Disease (AD)

Other(3)

Yale Alzheimer Disease Research Center

Super-resolution imaging of brain microvascular changes in a model of Alzheimer Disease

Alzheimer Disease Research Center

CYCLE-AD: Randomized Controlled Trial to Assess the Efficacy of Indoor Cycling in Slowing Disease Progression in Healthy Older Persons at Genetic Risk for Alzheimers Disease